Serina Therapeutics, Inc.SERNYSE
Loading
Gross Margin Over TimeExpanding
Percentile Rank67
3Y CAGR-17.1%
Studio
Year-over-Year Change

Gross profit as a percentage of revenue

3Y CAGR
-17.1%/yr
vs +25.9%/yr prior
Acceleration
-43.1pp
Decelerating
Percentile
P67
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM56.90%+123.1%
2024-246.43%-353.7%
202397.15%-2.9%
2022100.00%0.0%
2021100.00%+104.4%
2020-2272.22%-5482.3%
201942.22%+6.2%
201839.76%-22.4%
201751.21%+13.0%
201645.32%-